Plaintiff Awarded $140M in AndroGel Verdict
Filed in: AndroGel
References
Jones, D. N. (2017, October 5). 2nd Bellwether Jury Says AbbVie Owes AndroGel User $140M - Law360. Retrieved from https://www.law360.com/articles/971341/2nd-bellwether-jury-says-abbvie-owes-androgel-user-140m
Lakshman, K. M., & Basaria, S. (2009). Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785864/
Basaria, S., M.D., Coviello, A. D., M.D., & Travison, T. G., Ph.D. (n.d.). Adverse Events Associated with Testosterone Administration — NEJM. Retrieved from http://www.nejm.org/doi/full/10.1056/NEJMoa1000485
Lipson, P. (2015, August 19). Is testosterone treatment safe and effective? Retrieved from https://www.forbes.com/sites/peterlipson/2015/08/19/is-testosterone-treatment-safe-and-effective/#363b707a4f72
Raymond, N. (2017, October 05). Second U.S. jury finds AbbVie misrepresented risks of AndroGel. Retrieved from https://www.reuters.com/article/us-abbvie-androgel/second-u-s-jury-finds-abbvie-misrepresented-risks-of-androgel-idUSKBN1CA2SQ